×

RNS Number : 6973P

Osirium Technologies PLC

12 February 2019

 

 

For immediate release

12 February 2019

 

Osirium Technologies plc

 

("Osirium" or "Group")

 

Contract win with major UK provider of software and IT services

 

Osirium Technologies plc (AIM: OSI.L), a leading vendor of cloud-based cybersecurity software, is pleased to announce a contract win with a major UK provider of software and IT services to the public sector.

 

Under the terms of the contract Osirium will deliver its full PxM Platform including the Privileged Access Management, Privileged Task Management and Privileged Session Management modules. The license is initially for 250 devices of the three modules and is set to run for 12 months.  

 

The Osirium platform will enable the customer to develop secure, managed services with tight controls over access to systems, as well as detailed reporting.  

 

David Guyatt, Chief Executive Officer, commented: "Osirium is delighted to have been awarded this contract against competitive offerings and we look forward to working with the customer as a strategic partnership.  This win is evidence of how effective, secure service provision is becoming an important driver for the Privileged Acccess Management marketplace, and how Osirium uniquely addresses these challenges.  

 

Three factors stand out.  Osirium's Task Automation allows the customer to transform how they securely manage an ever increasing volume of repeated, routine but essential tasks.  Our licensing model makes it simple for them to scale and grow their secure services business without constraint. Finally, the flexibility and ease of use of the Osirium platform allow them to operate, manage and report on a wide and diverse range of environments."

 

 

–      Ends –

For further information:

Osirium Technologies plc	Tel: +44 (0) 118 324 2444
David Guyatt, Chief Executive Officer Rupert Hutton, Chief Financial Officer www.osirium.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Broker)	Tel: +44 (0) 20 7710 7600
Fred Walsh / Neil Shah / Alex Price
Yellow Jersey PR (Financial PR) Sarah Hollins Henry Wilkinson	Tel: +44 (0)7764 947 137 Tel: +44 (0)7951 402 336

 

Notes to Editors:

 

About Osirium

Osirium Technologies plc (AIM: OSI.L) operates in one of the fastest growing parts of the cybersecurity market and is a leading vendor of Privileged Access Management ("PAM") software. Osirium's cloud-based products protect critical IT assets, infrastructure and devices by preventing targeted cyber-attacks from directly accessing Privileged Accounts, removing unnecessary access and powers of Privileged Account users, deterring legitimate Privileged Account users from abusing their roles and containing the effects of a breach if one does happen.

 

Osirium has defined and delivered what the Directors view as the next generation PAM solution.  The team has developed the concept of a Virtual Air Gap to separate users from passwords.  Built on Robotic Automation technology, Osirium's Privileged Task Management module further strengthens Privileged Account security by minimising the cyber-attack surface and delivering an impressive return on investment benefits for customers.

 

Founded in 2008 and with its headquarters in Reading, UK, the Group was admitted to AIM in April 2016.  For further information please visit www.osirium.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTSFMEFFFUSELE

Close

×

RNS Number : 2979P

Crimson Tide PLC

07 February 2019

 

Crimson Tide Plc – TIDE

("Crimson Tide" or "the Company")

Contract Wins in the rail sector

Crimson Tide, the provider of mpro5, mobility as a service, announces a number of contract wins in the rail sector which have been achieved through its new partner channel.

An initial win has been gained with Arriva UK Trains subsidiary Chiltern Railways, with mpro5 providing mobile auditing solutions for train presentation. A further subscriber agreement has been signed with Northern Rail, where mpro5 will assist with staff management and station presentation.

These transactions have been won via our partner Graphite Partners, with assistance from our OEM partner Samsung Electronics. The best of breed approach for device, functionality, flexibility and deployment convinced Northern Rail to commit to a five year agreement.

With the full contract value of the agreements amounting to  nearly £250,000, the acquisition of these agreements represents a step forward in our engagement with the Rail and Transport industry with further opportunities being explored directly and with our partners' support.

Denis O'Sullivan, Train Presentation Manager for Chiltern Rail explains the value of mpro5 and the future prospects within Chiltern Railways:

"mpro5 has brought simplicity to what was an onerous auditing process, affording opportunity to quickly and accurately check standards against performance output. It has enabled us to capture data on standards in real time on our Samsung devices, supplying information and feedback to colleagues, highlighting findings, including example photographs. mpro5 collates statistical data and overall performance without the need to revisit findings. It provides strong graphical information that can simply be shared with colleagues at all levels, providing accurate information on overall performance. This enables us to focus on the required areas for improvement without having to trawl through large amounts of data. The prospects for the mpro5, Samsung and Chiltern Rail partnership in terms of potential seem endless."

Barrie Whipp, Executive Chairman commented:

"Following the development of our relationship with our partners we have entered another vertical market where mpro5 can deliver value and measurable ROI. With an expanding channel strategy we are able to get mpro5 in front of the right people, in the right context at the right time"

Enquiries:

Crimson Tide plc                                                                                                              01892 542444

Barrie Whipp / Luke Jeffrey

Arden Partners                                                                                                                 020 7614 5900

John Llewellyn-Lloyd / Dan Gee-Summons – Corporate Finance

Paul Brotherhood – Equity Sales

 

For further information on Crimson Tide plc, see the website at: www.crimsontide.co.uk/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAUGUBPPUPBGQQ

Close

×

RNS Number : 9501O

Transense Technologies PLC

04 February 2019

 

 

Transense Technologies plc 

("Transense" or the "Company")

 

GE Aviation Contract Win

Transense Technologies Plc (AIM: TRT), the provider of sensor systems for the transportation, automotive, avionic and industrial markets, is pleased to announce that their licensee GE Aviation (GE) T901-GE-900 engine has been selected by the U.S. Army for the Engineering and Manufacturing Development (EMD) phase of the Improved Turbine Engine Program (ITEP), the U.S. Army's endeavor to re-engine its Boeing AH-64 Apaches and Sikorsky UH-60 Black Hawks. The T901 engine incorporates a Transense Technologies Surface Acoustic Wave (SAW) sensor.

The US Army intends to replace the more than 6,000 engines installed in their current fleet of these two aircraft; the wider market for the T901 includes replacement engines for these aircraft in military forces outside of the USA as well as other military and commercial medium sized vertical take-off aircraft opportunities globally.

Transense's Graham Storey stated, "We are very proud of the involvement of Transense's SAW technology in this engine and look forward to working with GE in the future".

GE will pay a perpetual sales royalty to the Company in respect of each unit using the technology, under the license agreement previously announced by the Company in July 2016 and March 2017.

 

 

For further information please visit www.transense.co.uk or contact:

 

Transense Technologies Plc Graham Storey, Chief Executive	Tel: +44 (0) 1869 238380
finnCap Ed Frisby, Giles Rolls (Corporate Finance) Tim Redfern (ECM)	Tel: +44 (0) 20 7220 0500

 

 

 

About Transense Technologies

Based in Oxfordshire, UK, Transense has developed patent-protected sensor systems and supporting technology for use in a variety of diverse high growth markets. Transense's Surface Acoustic Wave (SAW), wireless, battery-less, sensor systems offer significant advantages over legacy wireless sensor systems. Transense is targeting the transport and mining industries, and the global torque, temperature and pressure sensing markets, via its trading divisions, Translogik and SAWSense.

Transense's shares are admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT).

www.transense.co.uk

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTSSUSMLFUSEFE

Close

×

Neville Registrars is delighted to welcome Herencia Resources plc as the newest addition to its list of client companies.

 

Herencia Resources plc is a multi-commodity resources company listed on the Alternative Investment Market (‘AIM’) of the London Stock Exchange.

 

Further information can be found on the Company's website: https://herenciaresources.com/

Close

×

Neville Registrars is delighted to welcome Mining, Minerals & Metals plc as the newest addition to its list of client companies.

 

 

Close

×

RNS Number : 0195O

Character Group PLC

24 January 2019

 

THE CHARACTER GROUP PLC

("Character", "Group" or "Company")

 

Designers, developers and international distributor of toys, games and giftware

 

 

Character named Supplier of the Year by UK Toy Industry Association

 

Company's service is recognised by retailers, in addition to picking up a Toy of the Year Award

 

 

 

LONDON: Thursday 24 January 2019: The Character Group plc (AIM: CCT) is delighted to announce that its principal trading subsidiary, Character Options Limited ("Character Options"), is celebrating two successes at the annual Toy Industry Awards at The London Toy Fair.

 

Each year the Toy Retailers Association announces at its annual awards ceremony at the London Toy Fair, not only which toys were most successful in the previous 12 months, but also which suppliers have performed best amongst their peers.  At this year's gathering, Character Options was awarded the coveted "Supplier of the Year" Award for the excellent standard of service to its customers.

 

Jon Diver, Joint MD at Character, commented:

 

"The Character Options team strives to give the best possible service to its customers whilst also supplying the highest quality and most sought-after children's toys.  We are delighted, therefore, to be recognised with this Supplier of the Year Award."

 

In addition, Soft 'n Slo Squishies was announced the winner of the Craze of the Year category. In an industry where trends are so dominant this brand was a top performing item and one of the best sellers for Character Options in 2018.

 

Two further Character Options brands received recognition with nominations in the categories; Peppa Pig in pre-school and Bubbleez as another brand in the craze category.

 

 

To watch the interview with Character discussing the ranges being shown at the Toy Fair please follow this link:

https://www.brrmedia.co.uk/broadcasts-embed/5c489294fb847413cc05168e/copied-from-5a69be0bcb01c41c2f977ee1?popup=true

 

 

The Character Group plc FTSE sector:  leisure: FTSE AIM All-share: symbol: CCT.L Market cap: £112m   Email:  [email protected] Group website: www.thecharacter.com

Product ranges can also be viewed at www.character-online.co.uk To find out more about PROXY, please visit the website at https://www.proxyas.com.

 

ENQUIRIES TO:   The Character Group plc Richard King, Non-Executive Chairman Kiran Shah, Joint Managing Director & Group Finance Director Jon Diver, Joint Managing Director

Office:      +44 (0) 208 329 3377 Mobile:    +44 (0) 7956 278522 (KS) Mobile:    +44 (0) 7831 802219 (JD)

Panmure Gordon (Nominated Adviser and Joint Broker) Atholl Tweedie, Investment Banking Charles Leigh-Pemberton, Corporate Broking Tel:  +44 (0) 20 7886 2500

TooleyStreet Communications Limited (Investor and media relations) Fiona Tooley Tel:  +44 (0) 7785 703523 Email: [email protected]

Evolution PR (Trade and consumer media) Michele Bates Tel: +44 (0) 01327 227010 Email: [email protected]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAEAEFLADANEFF

Close

×

Neville Registrars is delighted to welcome Dev Clever Holdings plc as the newest addition to its list of client companies.

 

DevClever, is a software development company established in 2014.  It has grown into a credible, recognised digital innovation brand, and has a range of blue-chip clients and educator customers, primarily within the UK.

 

Further information can be found on the Company's website: https://www.devclever.co.uk/

Close

×

RNS Number : 4440N

LoopUp Group PLC

18 January 2019

 

18 January 2019

LOOPUP GROUP PLC

 ("LoopUp Group" or the "Group")

 

Contract Renewal with Clifford Chance

 

LoopUp Group plc (LSE AIM: LOOP), the premium remote meetings company, is pleased to announce that it has signed a material contract renewal with leading global law firm, Clifford Chance.

The minimum total contract value of £2.34 million in aggregate over the 3-year term is for the provision of conference calls across Clifford Chance's global operations, spanning 32 major financial centres in the Americas, Asia Pacific, Europe, the Middle East and Africa.

The LoopUp product is typically offered on a pay-as-you-go, per minute per guest basis. However, this renewal with Clifford Chance on a guaranteed minimum spend basis is a mark of their commitment to the Group's differentiated product over the long-term.

 

Paul Greenwood, CIO of Clifford Chance, commented:

 

"Within our Innovation and Best Delivery strategy, we consider how investing in smart technology and applying our extensive legal expertise can improve value and outcomes for clients, making our service delivery more effective, every time. Technology can tackle complex challenges, but it can also be extremely powerful by making simple improvements to important tasks undertaken regularly. Conference calling from LoopUp is a great example of this: benefits such as seeing who is on the conference call or and being able to screen share easily offer significant improvement to the client experience. Our people have really taken to LoopUp, and we're pleased to demonstrate our commitment to the company and product with this major renewal."

 

Steve Flavell, co-CEO of LoopUp Group, commented:

 

"We're delighted to extend our relationship with Clifford Chance. Conference calls form a critical component of the firm's important day-to-day interactions with their clients. The quality of these calls – both from a user experience and audio quality perspective – is paramount, and we're delighted to receive this endorsement in our product and customer service from such a leading global firm."

 

The Group will announce a trading update for the financial year ended 31 December 2018 on 12 February 2019.

 

 

The information in this announcement is inside information for the purposes of Article 7 of the Market Abuse Regulation 596/2014.

 

 

For further information, please contact:

 

LoopUp Group plc	via FTI
Steve Flavell, co-CEO
Panmure Gordon (UK) Limited	+44 (0) 20 7886 2500
Dominic Morley / Alina Vaskina (Corporate Finance)
Erik Anderson (Corporate Broking)
Numis Securities Limited	+44 (0) 20 7260 1000
Simon Willis / Jonny Abbott (Corporate Finance)
Tom Ballard (Corporate Broking)
FTI Consulting, LLP	+44 (0) 20 3727 1000
Matt Dixon / Harry Staight

 

 

About Clifford Chance

 

Clifford Chance is one of the world's pre-eminent law firms with significant depth and range of resources across five continents. As a single, fully integrated global partnership, we pride ourselves on our approachable, collegial and team-based way of working. We always strive to exceed the expectations of our clients, which include corporates from all commercial and industrial sectors, governments, regulators, trade bodies and not-for-profit organisations. We provide them with the highest-quality advice and legal insight, which combines the firm's global standards with in-depth local expertise.

 

For more information, please see www.cliffordchance.com and www.linkedin.com/company/clifford-chance-llp.

 

 

About LoopUp Group plc

 

LoopUp (LSE AIM: LOOP) is a premium remote meetings solution. Streamlined and intuitive, LoopUp is built to give mainstream business professionals a better and more productive experience than basic dial-in conferencing, while delivering the quality, security and reliability required in the enterprise. One-click screen sharing and integration with tools business people use every day, like Outlook™, make it easy for LoopUp users to collaborate in real time. LoopUp's award-winning SaaS solution doesn't overwhelm users with features and doesn't require training. Over 2,000 enterprises worldwide, including Travelex, Kia Motors America, Planet Hollywood, National Geographic and Clifford Chance trust LoopUp with their remote meetings.

 

The Group is headquartered in London, with offices in San Francisco, New York, Boston, Denver, Cardiff, Berlin, Malmo, Hong Kong, Sydney and Barbados, and is listed on the AIM market of the London Stock Exchange (LOOP). For further information, please visit: www.loopup.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

CNTSFAESWFUSEFF

Close

×

RNS Number : 7990M

ValiRx PLC

11 January 2019

 

 

 

 

VALIRX PLC

("ValiRx" or the "Company")

 

UPDATE ON VAL401

"Publication of article in the 'European Journal of Drug Metabolism and Pharmacokinetics"

"First published peer-reviewed journal article on VAL401 clinical trial results"

 

London, UK., 11 January 2019: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, is pleased to announce that further to its announcement on 18 December 2018, the Company notes that its peer-reviewed article, entitled: "Clinical Pharmacokinetics of a Lipid-Based Formulation of Risperidone, VAL401: Analysis of a Single Dose in an Open-Label Trial of Late-Stage Cancer Patients", has now been published online in the European Journal of Drug Metabolism and Pharmacokinetics and can be viewed via the following link: Dilly, S.J., Morris, G.S., Taylor, P.C. et al. Eur J Drug Metab Pharmacokinet (2019). https://doi.org/10.1007/s13318-018-00538-4

 

 

*** ENDS ***

 

For more information, please contact:

 

ValiRx plc	Tel: +44 (0) 20 3008 4416 www.valirx.com
Dr Satu Vainikka, Chief Executive	Tel: +44 (0) 20 3008 4416
Tarquin Edwards, Head of Communications.	Tel: +44 (0) 7879 458 364 [email protected]
Novum Securities Limited Colin Rowbury	Tel: +44 (0) 20 7399 9400

 

Notes for Editors

About ValiSeek

ValiSeek Limited ("ValiSeek") is a joint venture ("JV") company between ValiRx Plc and Tangent Reprofiling Limited, part of the SEEK Group. ValiSeek was formed to progress the drug VAL401 through its remaining preclinical development and towards Phase II trials for the treatment of lung cancer and other oncology indications.

 

About ValiRx

ValiRx is a biotechnology oncology focused company specialising in developing novel treatments for cancer and associated biomarkers.  It aims to make a significant contribution in "precision" medicine and science, namely to engineer a breakthrough into human health and well-being, through the early detection of cancer and its therapeutic intervention.

 

The Company's business model focuses on out-licensing therapeutic candidates early in the development process.  By aiming for early-stage value creation, the company reduces risk considerably while increasing the potential for realising value.  The group is already in licensing discussions with major players in the oncology field.

 

ValiRx's two classes of drugs in development, which each have the potential for meeting hitherto unmet medical needs by existing methods, have worldwide patent filings and agreed commercial rights.   They originate or derive from World class institutions, such as Cancer Research UK and Imperial College.

 

Until recently, cancer treatments relied on non-specific agents, such as chemotherapy.  With the development of target-based agents, primed to attack cancer cells only, less toxic and more effective treatments are now possible.  New drugs in this group-such as those in ValiRx's pipeline-promise to greatly improve outcomes for cancer patients.

 

The Company listed on the AIM Market of the London Stock Exchange in October 2006 and trades under the ticker symbol: VAL

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRASFFFMSFUSESF

Close

×

RNS Number : 8124M

Microsaic Systems plc

11 January 2019

 

11 January 2019

Microsaic Systems plc

 

("Microsaic" or the "Company")

 

Microsaic announces new protein identification product

 

Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry ("MS") instruments, announces the introduction of its new protein identification technology.

 

The Microsaic MiD® ProteinID is a break-through mass identification technique that allows users to verify target proteins throughout the whole bioprocessing value chain. By providing deterministic characterisation for proteins and small molecules at the point of need, the Microsaic MiD® ProteinID offers fast results over a mass range of 50-3,200 m/z, the broadest mass coverage for a small footprint mass spectrometer. Driven by design, the Microsaic MiD® ProteinID is transformational for process analytics, as its abilities as a point-of-need technology are derived from simplicity, and low maintenance which allows for minimal down-time and greater confidence in results.

 

Biologic drugs represented eight out of ten top selling drugs in 2016, with expected revenues in 2019 of c$445Bn. Revenues are c$15Bn from the top eight suppliers of manufacturing equipment into this industry.

Biologic manufacture demands real-time analysis throughout the entire process. The Microsaic MiD® ProteinID provides real time analysis from the raw in-coming goods, to upstream 'in-cell' drug production, and subsequent downstream product purification.

The Microsaic MiD® ProteinID was ranked among the top innovative products of the year by The Analytical Scientist Innovation Awards in December 2018.

 

Glenn Tracey, CEO of Microsaic, commented, "Bringing the power of the centralised laboratory to in-situ bioprocessing line measurements, the Microsaic MiD® ProteinID reduces key bioprocessing analyses from days to minutes. This means that operators can monitor feedstocks, metabolites and target proteins in just one measurement, thus accelerating time-to-market for new biologics development. Mass spectrometry can now offer superlative performance to high value manufacturing industries at the point-of-need, providing much greater insights over ubiquitous optical sensors."

 

 

Enquiries:
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD	+44 (0) 1483 751 577
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking)	+44 (0)20 7496 3000
IFC Advisory Ltd (Financial PR) Graham Herring Heather Armstrong Florence Chandler	+44 (0)20 3934 6630

 

 

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D and manufacturing.  The Company works with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines.  MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

 

The Microsaic's compact MiD® MS systems retain the functionality of larger conventional MS systems, while being easier to use by non-specialists, and consume less energy and have lower running costs. For more information, please go to www.microsaic.com.  

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 

END

 

 

NRAURRWRKBAAAAR

Close